SEARCH

SEARCH BY CITATION

References

  • 1
    Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. In: Terasaki PI, Cecka JM (eds). Clinical transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997;1530.
  • 2
    Everhart JE, Wei Y, Eng H, Charlton MR, Persing DH, Wiesner RH, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 1999; 29:12201226.
  • 3
    Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203210.
  • 4
    Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994; 20(suppl):S24S27.
  • 5
    Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:11371143.
  • 6
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28:823830.
  • 7
    Gayowski T, Singh N, Marino IR, Vargas H, Wagener M, Wannstedt C, et al. Hepatitis C virus genotypes in liver transplant recipients: Impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997; 64:422426.
  • 8
    Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992; 89:13611365.
  • 9
    Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996; 62:17731776.
  • 10
    Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, Corless CL. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998; 65:11781182.
  • 11
    Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000; 32:673684.
  • 12
    Anonymous. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25:658663.
  • 13
    Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696699.
  • 14
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis genotype 1b infection following liver transplantation: Relationship with rejection episodes. Hepatology 1999; 29:250256.
  • 15
    Feray C, Habsanne A, Samuel D, Farges O, Reynes M, Bismuth H, et al. Poor prognosis of patients retransplanted for recurrent liver disease due to hepatitis c virus [abstract]. Hepatology 1995; 22:135A.
  • 16
    Singh N, Gayowski T, Wannstedt C, Shakil AO, Wagener MM, Fung JJ, Marino IR. Interferon-α for prophylaxis of recurrent hepatitis C in liver transplant recipients. Transplantation 1998; 65:8286.
  • 17
    Sheiner P, Boros P, Klion FM, Thung SN, Schluger LK, Lau JY, et al. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998; 28:831838.
  • 18
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815820.
  • 19
    Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, et al. Interferon-alpha therapy for hepatitis C infection after liver transplantation. Hepatology 1994; 20:773779.
  • 20
    Gane EJ, Lo SK, Riordan SM, Portmann BC, Lau JY, Naoumov NV, Williams R. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998; 27:14031407.
  • 21
    McHutchison JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis 1999; 19(suppl 1):S57S65.
  • 22
    Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, et al. Randomised trial of interferon-α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon-α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352:14261432.
  • 23
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339:14851492.
  • 24
    Dousset B, Conti F, Houssin D, Calmus Y. Acute vanishing bile duct syndrome after interferon-α therapy for recurrent HCV infection in liver transplant recipients. N Engl J Med 1994; 330:11601161.
  • 25
    Feray C, Samuel D, Gigou M, Paradis V, Reynes M, Bismuth H. An open trial of interferon-α recombinant for hepatitis C after liver transplantation. Hepatology 1995; 22:10841089.
  • 26
    Ahmed J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO. Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl 2001; 7:863869.
  • 27
    Boillot O, Berger F, Rasolofo E, Mion F, Chevalier P, Gille D, Paliard P. Effectiveness of early alpha-interferon therapy for hepatitis C infection recurrence after liver transplantation. Transplant Int 1996; 9(suppl 1):S202S203.
  • 28
    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliot M, Baulieux J, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26:500504.
  • 29
    Fischer L, Sterneck M, Valentin-Gamazo C, Feucht HH, Malago M, Broelsch CE. Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha. Transplant Proc 1999; 31:494495.
  • 30
    Gopal DV, Rabkin JM, Berk BS, Corless CL, Chou S, Olyaei A, et al. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl 2001; 7:181190.
  • 31
    Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO. Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl 2001; 7:863869.
  • 32
    Alberti AB, Belli LS, Airoldi A, de Carlis L, Rondinara G, Minola E, et al. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study. Liver Transpl 2001;870876.
  • 33
    De Vera ME, Smallwood GA, Rosado K, Davis L, Martinez E, Sharma S, et al. Interferon-α and ribavirin for the treatment of recurrent hepatitis C after liver transplantation. Transplantation 2001; 71:678686.